EX-16.1 2 v334864_ex16-1.htm EXHIBIT 16-1

February12, 2013

Office of the Chief Accountant

Securities and Exchange Commission

100 F Street, N. E.

Washington, D.C. 20549

Ladies and Gentlemen:

We have read the comments made regarding us in Item 4.01 (a) of Form 8-K of Bioanalytical Systems, Inc. dated February 12, 2013 and are in agreement with those statements.

Crowe Horwath LLP

Fort Wayne, Indiana

cc:	Mr. Larry Boulet
	Audit Committee Chairman
	Bioanalytical Systems, Inc.